Efficacy of Stellate Ganglion Block in Children With Autistic Disorder (SGB-gudu)

Z

Zeng Changhao

Status

Withdrawn

Conditions

Autistic Disorder

Treatments

Procedure: Stellate ganglion block
Behavioral: Routine therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06228157
2024-KY-0119-018

Details and patient eligibility

About

The goal of this clinical trial is to explore efficacy of stellate ganglion block Children with Autistic Disorder. The main question it aims to answer is: Can stellate ganglion block improve the Autistic Disorder in children? Children with Autistic Disorder will be divided into the control group and experimental group evenly. All the patients were provided with routine therapy, while the patients in the experimental group were given stellate ganglion block. The Childhood Autism Rating Scale of the two groups of patients before and after treatment are evaluated.

Full description

Autistic Disorder in children is becoming increasingly more. The goal of this clinical trial is to explore efficacy of stellate ganglion block Children with Autistic Disorder. The main question it aims to answer is: Can stellate ganglion block improve the Autistic Disorder in children? Children with Autistic Disorder will be divided into the control group and experimental group evenly. All the patients were provided with routine therapy, while the patients in the experimental group were given stellate ganglion block. The Childhood Autism Rating Scale of the two groups of patients before and after treatment are evaluated.

Sex

All

Ages

6 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed as Autistic Disorder.
  • Aged between 6 years old and 12 years old.
  • No contraindications to stellate ganglion block.

Exclusion criteria

  • Other significant physical or neurodevelopmental disorders.
  • Other significant medical conditions

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

0 participants in 2 patient groups

the experimental group
Experimental group
Description:
The study lasts 20d for each patient. During the treatment, All the participants are provided with the routine rehabilitation therapy. Based on the invention above, the patients in the experimental group were provided with stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g)
Treatment:
Behavioral: Routine therapy
Procedure: Stellate ganglion block
the control group
Active Comparator group
Description:
The study lasts 20d for each patient. During the treatment, All the participants are provided with the routine rehabilitation therapy.
Treatment:
Behavioral: Routine therapy

Trial contacts and locations

1

Loading...

Central trial contact

Zhefeng Wang, Doctor; Weijia Zhao, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems